ICU Medical Net Worth
ICU Medical Net Worth Breakdown | ICUI |
ICU Medical Net Worth Analysis
ICU Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ICU Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ICU Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ICU Medical's net worth analysis. One common approach is to calculate ICU Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ICU Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ICU Medical's net worth. This approach calculates the present value of ICU Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ICU Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ICU Medical's net worth. This involves comparing ICU Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ICU Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if ICU Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ICU Medical's net worth research are outlined below:
| ICU Medical generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 2.38 B. Net Loss for the year was (117.69 M) with profit before overhead, payroll, taxes, and interest of 824.78 M. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Water for Injection Market Sales to Hit US 71.7 Billion by 2035, Boosted by Increasing Demand for High-Purity Water in Healthcare Latest Report by TMR |
ICU Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ICU Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ICU Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
ICU Medical Target Price Consensus
ICU target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. ICU Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 6 | Buy |
Most ICU analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand ICU stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of ICU Medical, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationICU Medical Target Price Projection
ICU Medical's current and average target prices are 149.21 and 203.40, respectively. The current price of ICU Medical is the price at which ICU Medical is currently trading. On the other hand, ICU Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
ICU Medical Market Quote on 18th of March 2025
Target Price
Analyst Consensus On ICU Medical Target Price
Know ICU Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ICU Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ICU Medical backward and forwards among themselves. ICU Medical's institutional investor refers to the entity that pools money to purchase ICU Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Schroder Investment Management Group | 2024-12-31 | 499.8 K | Neuberger Berman Group Llc | 2024-12-31 | 478.7 K | Fmr Inc | 2024-12-31 | 475.9 K | Northern Trust Corp | 2024-12-31 | 402.3 K | Citadel Advisors Llc | 2024-12-31 | 391.5 K | Silvercrest Asset Management Group Llc | 2024-12-31 | 358.4 K | Btim Corp | 2024-12-31 | 317.2 K | Segall Bryant & Hamill | 2024-12-31 | 306.8 K | Charles Schwab Investment Management Inc | 2024-12-31 | 304.2 K | Blackrock Inc | 2024-12-31 | 3.7 M | Vanguard Group Inc | 2024-12-31 | 2.7 M |
Follow ICU Medical's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.52 B.Market Cap |
|
Project ICU Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | (0.03) | (0.03) | |
| Return On Equity | (0.06) | (0.06) |
When accessing ICU Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ICU Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ICU Medical's profitability and make more informed investment decisions.
Evaluate ICU Medical's management efficiency
ICU Medical has return on total asset (ROA) of 0.0142 % which means that it generated a profit of $0.0142 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0576) %, meaning that it created substantial loss on money invested by shareholders. ICU Medical's management efficiency ratios could be used to measure how well ICU Medical manages its routine affairs as well as how well it operates its assets and liabilities. The ICU Medical's current Return On Tangible Assets is estimated to increase to -0.06. The current Return On Capital Employed is estimated to decrease to 0.01. As of now, ICU Medical's Total Current Assets are increasing as compared to previous years. The ICU Medical's current Other Current Assets is estimated to increase to about 363.3 M, while Net Tangible Assets are forecasted to increase to (373.7 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 80.58 | 84.61 | |
| Tangible Book Value Per Share | (8.54) | (8.12) | |
| Enterprise Value Over EBITDA | 117.74 | 123.63 | |
| Price Book Value Ratio | 1.93 | 3.58 | |
| Enterprise Value Multiple | 117.74 | 123.63 | |
| Price Fair Value | 1.93 | 3.58 | |
| Enterprise Value | 436.6 M | 243.3 M |
ICU Medical benefits from a management team that prioritizes both innovation and efficiency. We analyze these priorities to gauge the stock's future performance.
Enterprise Value Revenue 2.0338 | Revenue | Quarterly Revenue Growth 0.071 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ICU Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on ICU Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ICU Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ICU Medical Corporate Filings
F4 | 14th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
ICU Medical Earnings Estimation Breakdown
The calculation of ICU Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of ICU Medical is estimated to be 1.28 with the future projection ranging from a low of 1.17 to a high of 1.44. Please be aware that this consensus of annual earnings estimates for ICU Medical is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
1.17 Lowest | Expected EPS | 1.44 Highest |
ICU Medical Earnings Projection Consensus
Suppose the current estimates of ICU Medical's value are higher than the current market price of the ICU Medical stock. In this case, investors may conclude that ICU Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and ICU Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2025 | Current EPS (TTM) | |
| 6 | 80.89% | 2.11 | 1.28 | -4.83 |
ICU Medical Earnings History
Earnings estimate consensus by ICU Medical analysts from Wall Street is used by the market to judge ICU Medical's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only ICU Medical's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.ICU Medical Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ICU Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ICU Medical Earnings per Share Projection vs Actual
Actual Earning per Share of ICU Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering ICU Medical predict the company's earnings will be in the future. The higher the earnings per share of ICU Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.ICU Medical Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as ICU Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of ICU Medical should always be considered in relation to other companies to make a more educated investment decision.ICU Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact ICU Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-25 | 2024-12-31 | 1.482 | 2.11 | 0.628 | 42 | ||
2024-11-12 | 2024-09-30 | 1.25 | 1.59 | 0.34 | 27 | ||
2024-08-07 | 2024-06-30 | 1 | 1.56 | 0.56 | 56 | ||
2024-05-07 | 2024-03-31 | 0.82 | 0.96 | 0.14 | 17 | ||
2024-02-27 | 2023-12-31 | 1.19 | 1.57 | 0.38 | 31 | ||
2023-11-06 | 2023-09-30 | 1.39 | 1.57 | 0.18 | 12 | ||
2023-08-07 | 2023-06-30 | 1.6 | 1.88 | 0.28 | 17 | ||
2023-05-08 | 2023-03-31 | 1.43 | 1.74 | 0.31 | 21 | ||
2023-02-27 | 2022-12-31 | 1.56 | 1.6 | 0.04 | 2 | ||
2022-11-07 | 2022-09-30 | 1.46 | 1.75 | 0.29 | 19 | ||
2022-08-08 | 2022-06-30 | 1.66 | 1.37 | -0.29 | 17 | ||
2022-05-09 | 2022-03-31 | 1.78 | 1.82 | 0.04 | 2 | ||
2022-02-24 | 2021-12-31 | 1.64 | 1.82 | 0.18 | 10 | ||
2021-11-03 | 2021-09-30 | 1.8 | 2.07 | 0.27 | 15 | ||
2021-08-04 | 2021-06-30 | 1.64 | 1.88 | 0.24 | 14 | ||
2021-05-06 | 2021-03-31 | 1.5 | 1.62 | 0.12 | 8 | ||
2021-02-25 | 2020-12-31 | 1.51 | 1.77 | 0.26 | 17 | ||
2020-11-05 | 2020-09-30 | 1.31 | 1.9 | 0.59 | 45 | ||
2020-08-10 | 2020-06-30 | 1.24 | 1.65 | 0.41 | 33 | ||
2020-05-07 | 2020-03-31 | 1.63 | 1.81 | 0.18 | 11 | ||
2020-02-27 | 2019-12-31 | 1.63 | 1.94 | 0.31 | 19 | ||
2019-11-11 | 2019-09-30 | 1.62 | 1.65 | 0.03 | 1 | ||
2019-08-07 | 2019-06-30 | 2.06 | 1.99 | -0.07 | 3 | ||
2019-05-09 | 2019-03-31 | 2.17 | 2.58 | 0.41 | 18 | ||
2019-02-28 | 2018-12-31 | 1.8 | 2.07 | 0.27 | 15 | ||
2018-11-08 | 2018-09-30 | 1.51 | 1.85 | 0.34 | 22 | ||
2018-08-09 | 2018-06-30 | 1.82 | 2.66 | 0.84 | 46 | ||
2018-05-09 | 2018-03-31 | 1.84 | 2.26 | 0.42 | 22 | ||
2018-03-01 | 2017-12-31 | 1.04 | 2.98 | 1.94 | 186 | ||
2017-11-09 | 2017-09-30 | 0.76 | 1.12 | 0.36 | 47 | ||
2017-08-09 | 2017-06-30 | 0.77 | 0.76 | -0.01 | 1 | ||
2017-05-10 | 2017-03-31 | 0.46 | 1.68 | 1.22 | 265 | ||
2017-03-01 | 2016-12-31 | 1.19 | 1.2 | 0.01 | 0 | ||
2016-11-09 | 2016-09-30 | 1.17 | 1.35 | 0.18 | 15 | ||
2016-08-08 | 2016-06-30 | 1.05 | 1.15 | 0.1 | 9 | ||
2016-05-10 | 2016-03-31 | 1.01 | 1.14 | 0.13 | 12 | ||
2016-02-03 | 2015-12-31 | 0.96 | 0.96 | 0.0 | 0 | ||
2015-11-05 | 2015-09-30 | 0.84 | 1.0 | 0.16 | 19 | ||
2015-08-10 | 2015-06-30 | 0.69 | 0.97 | 0.28 | 40 | ||
2015-05-05 | 2015-03-31 | 0.62 | 1.02 | 0.4 | 64 | ||
2015-02-09 | 2014-12-31 | 0.59 | 0.68 | 0.09 | 15 | ||
2014-11-10 | 2014-09-30 | 0.48 | 0.66 | 0.18 | 37 | ||
2014-08-11 | 2014-06-30 | 0.34 | 0.38 | 0.04 | 11 | ||
2014-05-06 | 2014-03-31 | 0.32 | 0.43 | 0.11 | 34 | ||
2014-02-12 | 2013-12-31 | 0.73 | 0.86 | 0.13 | 17 | ||
2013-10-21 | 2013-09-30 | 0.67 | 0.72 | 0.05 | 7 | ||
2013-07-18 | 2013-06-30 | 0.66 | 0.48 | -0.18 | 27 | ||
2013-04-22 | 2013-03-31 | 0.44 | 0.58 | 0.14 | 31 | ||
2013-02-04 | 2012-12-31 | 0.78 | 0.82 | 0.04 | 5 | ||
2012-10-15 | 2012-09-30 | 0.68 | 0.82 | 0.14 | 20 | ||
2012-07-16 | 2012-06-30 | 0.59 | 0.63 | 0.04 | 6 | ||
2012-04-16 | 2012-03-31 | 0.48 | 0.53 | 0.05 | 10 | ||
2012-01-30 | 2011-12-31 | 0.62 | 0.7 | 0.08 | 12 | ||
2011-10-17 | 2011-09-30 | 0.58 | 0.65 | 0.07 | 12 | ||
2011-07-18 | 2011-06-30 | 0.56 | 0.67 | 0.11 | 19 | ||
2011-04-18 | 2011-03-31 | 0.47 | 0.57 | 0.1 | 21 | ||
2011-01-31 | 2010-12-31 | 0.53 | 0.72 | 0.19 | 35 | ||
2010-10-18 | 2010-09-30 | 0.48 | 0.65 | 0.17 | 35 | ||
2010-07-19 | 2010-06-30 | 0.37 | 0.56 | 0.19 | 51 | ||
2010-04-19 | 2010-03-31 | 0.41 | 0.3 | -0.11 | 26 | ||
2010-02-01 | 2009-12-31 | 0.48 | 0.5 | 0.02 | 4 | ||
2009-10-19 | 2009-09-30 | 0.32 | 0.42 | 0.1 | 31 | ||
2009-07-20 | 2009-06-30 | 0.35 | 0.38 | 0.03 | 8 | ||
2009-04-16 | 2009-03-31 | 0.33 | 0.47 | 0.14 | 42 | ||
2009-02-02 | 2008-12-31 | 0.43 | 0.61 | 0.18 | 41 | ||
2008-10-16 | 2008-09-30 | 0.41 | 0.52 | 0.11 | 26 | ||
2008-07-17 | 2008-06-30 | 0.28 | 0.33 | 0.05 | 17 | ||
2008-04-17 | 2008-03-31 | 0.32 | 0.2 | -0.12 | 37 | ||
2008-01-28 | 2007-12-31 | 0.4 | 0.41 | 0.01 | 2 | ||
2007-10-18 | 2007-09-30 | 0.35 | 0.31 | -0.04 | 11 | ||
2007-07-18 | 2007-06-30 | 0.38 | 0.37 | -0.01 | 2 | ||
2007-04-18 | 2007-03-31 | 0.49 | 0.29 | -0.2 | 40 | ||
2007-01-29 | 2006-12-31 | 0.42 | 0.44 | 0.02 | 4 | ||
2006-10-18 | 2006-09-30 | 0.39 | 0.39 | 0.0 | 0 | ||
2006-07-18 | 2006-06-30 | 0.37 | 0.4 | 0.03 | 8 | ||
2006-04-18 | 2006-03-31 | 0.33 | 0.41 | 0.08 | 24 | ||
2006-01-30 | 2005-12-31 | 0.3 | 0.35 | 0.05 | 16 | ||
2005-10-18 | 2005-09-30 | 0.19 | 0.38 | 0.19 | 100 | ||
2005-07-18 | 2005-06-30 | 0.22 | 0.31 | 0.09 | 40 | ||
2005-04-18 | 2005-03-31 | 0.22 | 0.3 | 0.08 | 36 | ||
2005-02-02 | 2004-12-31 | -0.13 | -0.11 | 0.02 | 15 | ||
2004-10-18 | 2004-09-30 | 0.2 | -0.08 | -0.28 | 140 | ||
2004-07-16 | 2004-06-30 | 0.29 | 0.23 | -0.06 | 20 | ||
2004-04-15 | 2004-03-31 | 0.28 | 0.28 | 0.0 | 0 | ||
2004-02-02 | 2003-12-31 | 0.47 | 0.48 | 0.01 | 2 | ||
2003-10-16 | 2003-09-30 | 0.33 | 0.28 | -0.05 | 15 | ||
2003-07-17 | 2003-06-30 | 0.38 | 0.26 | -0.12 | 31 | ||
2003-04-17 | 2003-03-31 | 0.36 | 0.46 | 0.1 | 27 | ||
2003-02-03 | 2002-12-31 | 0.38 | 0.38 | 0.0 | 0 | ||
2002-10-17 | 2002-09-30 | 0.28 | 0.28 | 0.0 | 0 | ||
2002-07-18 | 2002-06-30 | 0.32 | 0.32 | 0.0 | 0 | ||
2002-04-18 | 2002-03-31 | 0.29 | 0.3 | 0.01 | 3 | ||
2002-02-04 | 2001-12-31 | 0.31 | 0.33 | 0.02 | 6 | ||
2001-10-18 | 2001-09-30 | 0.21 | 0.23 | 0.02 | 9 | ||
2001-07-18 | 2001-06-30 | 0.25 | 0.26 | 0.01 | 4 | ||
2001-04-18 | 2001-03-31 | 0.26 | 0.25 | -0.01 | 3 | ||
2001-01-29 | 2000-12-31 | 0.26 | 0.27 | 0.01 | 3 | ||
2000-10-18 | 2000-09-30 | 0.2 | 0.15 | -0.05 | 25 | ||
2000-07-18 | 2000-06-30 | 0.21 | 0.22 | 0.01 | 4 | ||
2000-04-18 | 2000-03-31 | 0.21 | 0.22 | 0.01 | 4 | ||
2000-01-31 | 1999-12-31 | 0.17 | 0.24 | 0.07 | 41 | ||
1999-10-18 | 1999-09-30 | 0.15 | 0.15 | 0.0 | 0 | ||
1999-07-15 | 1999-06-30 | 0.17 | 0.17 | 0.0 | 0 | ||
1999-04-15 | 1999-03-31 | 0.16 | 0.17 | 0.01 | 6 | ||
1999-02-01 | 1998-12-31 | 0.16 | 0.16 | 0.0 | 0 | ||
1998-10-15 | 1998-09-30 | 0.14 | 0.15 | 0.01 | 7 | ||
1998-07-16 | 1998-06-30 | 0.13 | 0.13 | 0.0 | 0 | ||
1998-04-16 | 1998-03-31 | 0.13 | 0.13 | 0.0 | 0 | ||
1998-02-02 | 1997-12-31 | 0.12 | 0.14 | 0.02 | 16 | ||
1997-10-16 | 1997-09-30 | 0.1 | 0.12 | 0.02 | 20 | ||
1997-07-17 | 1997-06-30 | 0.09 | 0.11 | 0.02 | 22 | ||
1997-04-17 | 1997-03-31 | 0.08 | 0.11 | 0.03 | 37 | ||
1997-02-03 | 1996-12-31 | 0.09 | 0.07 | -0.02 | 22 | ||
1996-10-18 | 1996-09-30 | 0.09 | 0.07 | -0.02 | 22 | ||
1996-07-18 | 1996-06-30 | 0.11 | 0.09 | -0.02 | 18 | ||
1996-04-18 | 1996-03-31 | 0.1 | 0.12 | 0.02 | 20 | ||
1996-02-06 | 1995-12-31 | 0.09 | 0.09 | 0.0 | 0 | ||
1995-10-18 | 1995-09-30 | 0.07 | 0.07 | 0.0 | 0 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (4.83) | Revenue Per Share | Quarterly Revenue Growth 0.071 | Return On Assets |
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.